Nutex Health Inc. (NUTX)

Accolade Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	624.28	479.95	247.65	219.29	331.53	274.03
Revenue Growth (YoY)	141.25%	93.80%	12.93%	-33.85%	20.98%	182.34%
Cost of Revenue	299.96	264.72	195.28	190.74	144.59	104.56
Gross Profit	324.32	215.23	52.37	28.55	186.94	169.47
Selling, General & Admin	59.93	58.56	36.07	20	5.46	10.4
Operating Expenses	115.86	77.53	53.66	33.13	13.12	16.29
Operating Income	208.46	137.71	-1.29	-4.58	173.82	153.17
Interest Expense	-21.61	-19.93	-16.32	-12.49	-6.2	-6.43
Other Non Operating Income (Expenses)	-7.11	-0.94	-0.4	-0.56	-0.12	-1
EBT Excluding Unusual Items	179.75	116.83	-18.01	-17.63	167.5	145.74
Merger & Restructuring Charges	-3.89	-3.89	-29.34	-3.89	-3.55	-
Impairment of Goodwill	-3.2	-3.2	-1.14	-398.14	-	-
Other Unusual Items	-	-	-	-	5.55	-
Pretax Income	172.66	109.75	-48.49	-419.65	169.49	145.74
Income Tax Expense	32.63	14.48	-5.07	13.09	0.97	0.18
Earnings From Continuing Operations	140.04	95.27	-43.42	-432.74	168.53	145.56
Minority Interest in Earnings	-72.86	-43.09	-2.36	7.96	-35.93	-39.59
Net Income	67.18	52.18	-45.79	-424.78	132.59	105.97
Net Income to Common	67.18	52.18	-45.79	-424.78	132.59	105.97
Net Income Growth	-	-	-	-	25.12%	406.47%
Shares Outstanding (Basic)	5	5	4	4	4	4
Shares Outstanding (Diluted)	6	5	4	4	4	4
Shares Change (YoY)	24.00%	21.89%	4.15%	7.10%	-	-
EPS (Basic)	12.78	10.25	-10.39	-100.36	33.55	26.81
EPS (Diluted)	12.01	9.71	-10.39	-100.36	33.00	26.81
EPS Growth	-	-	-	-	23.07%	-
Free Cash Flow	69.43	20.85	-8.24	35.97	136.51	25.48
Free Cash Flow Per Share	12.35	3.88	-1.87	8.50	34.54	6.45
Gross Margin	51.95%	44.84%	21.14%	13.02%	56.39%	61.84%
Operating Margin	33.39%	28.69%	-0.52%	-2.09%	52.43%	55.90%
Profit Margin	10.76%	10.87%	-18.49%	-193.70%	39.99%	38.67%
Free Cash Flow Margin	11.12%	4.34%	-3.33%	16.41%	41.17%	9.30%
EBITDA	227.28	156.68	16.3	8.55	179.09	156.66
EBITDA Margin	36.41%	32.65%	6.58%	3.90%	54.02%	57.17%
D&A For EBITDA	18.81	18.97	17.59	13.13	5.27	3.48
EBIT	208.46	137.71	-1.29	-4.58	173.82	153.17
EBIT Margin	33.39%	28.69%	-0.52%	-2.09%	52.43%	55.90%
Effective Tax Rate	18.90%	13.19%	-	-	0.57%	0.12%
Revenue as Reported	624.28	479.95	247.65	219.29	331.53	274.03

Updated May 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q